Epsom Salt

Product NDC: 11673-602
11-digit product format: 116730602
Labeler code: 11673
Product ID: 11673-602_5aab3d93-ba62-36b5-e063-6394a90afa7c
Type: HUMAN OTC DRUG
Nonproprietary name: Magnesium Sulfate
Dosage form: GRANULE, FOR SOLUTION
Route: ORAL; TOPICAL
Labeler: Target Corporation
Application: M007
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 1996-12-12
Substance: MAGNESIUM SULFATE HEPTAHYDRATE
Active strength: 1 g/g
Pharmacologic classes: Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	11673-602	11673-602-01	D	Discontinued by firm		2026-10-15

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 20 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	11673-602-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	11673-602-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	11673-602-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	11673-602-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	11673-602-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	11673-602-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	11673-602-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	11673-602-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	11673-602-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	11673-602-01	`ad56d346431e…`	`cc804d4bbf1e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Epsom Salt
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
MAGNESIUM SULFATE HEPTAHYDRATE	1 g/g

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
SK47B8698T	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1053346	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
87f98e6c-a3a1-4ca5-bd56-977e38f48914	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2020-05-21	UP & UP 602.002/602AA Epsom Salt
2020-05-21	UP & UP 602.002/602AA Epsom Salt
2020-01-31	UP & UP 602.002/602AA Epsom Salt
2020-01-31	UP & UP 602.002/602AA Epsom Salt

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
MAGNESIUM SULFATE HEPTAHYDRATE	ACTIVE INGREDIENT	SK47B8698T	EPSOM SALT (MAGNESIUM SULFATE) GRANULE, FOR SOLUTION [TARGET CORPORATION]	3
MAGNESIUM CATION	ACTIVE MOIETY	T6V3LHY838	EPSOM SALT (MAGNESIUM SULFATE) GRANULE, FOR SOLUTION [TARGET CORPORATION]	3

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 26 of 42 · 833 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Womens Gentle Laxative	BISACODYL	BETTER LIVING BRANDS LLC.	f2c4ed1a-5aa4-1915-e053-2a95a90a59b6	2025-02-12	Warnings	Exact identifier application number: M007
Laxative	SENNOSIDES	BETTER LIVING BRANDS LLC.	f2c5c1e6-3123-c802-e053-2995a90aa073	2025-02-12	Warnings	Exact identifier application number: M007
Vegetable Laxative	SENNOSIDES	BETTER LIVING BRANDS LLC.	f2c529e4-6738-377c-e053-2995a90aaf38	2025-02-12	Warnings	Exact identifier application number: M007
WOMENS GENTLE LAXATIVE	BISACODYL	CVS HEALTH CORP	a95073f3-e1d6-d291-e053-2a95a90aefea	2025-02-12	Warnings	Exact identifier application number: M007
MAXIMUM STRENGTH LAXATIVE	SENNOSIDES	CVS HEALTH	b05ee52f-4801-d4ca-e053-2995a90af348	2025-02-12	Warnings	Exact identifier application number: M007
SENNA	SENNOSIDES	Reliable 1 Laboratories LLC	c8aa7ae9-7d00-db7d-e053-2995a90ae72b	2025-02-11	Warnings	Exact identifier application number: M007
Extra Gentle Laxative	BISACODYL	DOLGENCORP INC	be214c4e-f6db-cc8d-e053-2a95a90addf7	2025-02-10	Warnings	Exact identifier application number: M007
SENNA-S	DOCUSATE SODIUM AND SENNOSIDES	KROGER	a187045c-c9d6-592a-e053-2995a90adb83	2025-02-10	Warnings	Exact identifier application number: M007
SENNA TIME	SENNOSIDES	TIME CAP LABORATORIES, INC	18ec8127-422c-4c1a-8331-58dabce69969	2025-02-08	Warnings	Exact identifier application number: M007
SENNA TIME S	DOCUSATE SODIUM-SENNOSIDES	TIME CAP LABORATORIES, INC	dc491692-8d3a-4ccd-a17d-4c630f122595	2025-02-08	Warnings	Exact identifier application number: M007
LAX-TIME	SENNOSIDES	TIME CAP LABORATORIES, INC	74a627fc-00e5-eb78-e053-2991aa0abacc	2025-02-08	Warnings	Exact identifier application number: M007
SENNOSIDES AND DOCUSATE SODIUM	SENNOSIDES AND DOCUSATE SODIUM	TIME CAP LABORATORIES, INC	0ad617e0-10a6-44fa-be62-4f3cc725fb01	2025-02-08	Warnings	Exact identifier application number: M007
Sennosides and Docusate Sodium	SENNOSIDES, DOCUSATE SODIUM	Asclemed USA, Inc.	2db546de-20dc-4697-aff2-12471f073b1d	2025-02-08	Warnings	Exact identifier application number: M007
SENNOSIDES	SENNOSIDES	TIME CAP LABORATORIES, INC	7498f5fa-1739-bb6e-e053-2a91aa0a5404	2025-02-07	Warnings	Exact identifier application number: M007
Gentle Laxative	MAGNESIUM HYDROXIDE	WALMART INC.	26b9f247-c242-2925-e063-6394a90a68dd	2025-02-06	Warnings	Exact identifier application number: M007
Docusate Sodium	DOCUSATE SODIUM	PAI Holdings, LLC dba PAI Pharma	e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5	2025-02-06	Warnings	Exact identifier application number: M007
Docusate Sodium	DOCUSATE SODIUM	PD-Rx Pharmaceuticals, Inc.	6a7e4193-22d2-491e-9842-5c43f571fc65	2025-02-05	Warnings	Exact identifier application number: M007
Mineral oil	MINERAL OIL	Best Choice (Valu Merchandisers Company)	3ec8a716-60e0-4dfb-adae-ddc53c613935	2025-02-04	Warnings	Exact identifier application number: M007
DOCUSATE SODIUM 50MG SOFTGEL (RED)	DOCUSATE SODIUM	CVS Pharmacy	273e5b52-1cf9-2525-e063-6394a90a8b4f	2025-02-04	Warnings	Exact identifier application number: M007
Laxative	SENNOSIDES	WALGREENS	f0caba1d-0c09-8496-e053-2995a90a47cf	2025-01-30	Warnings	Exact identifier application number: M007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
SK47B8698T	MAGNESIUM SULFATE HEPTAHYDRATE	10034-99-8	MAGNESIUM SULFATE HEPTAHYDRATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
11673-602-01	11673060201	1814 g in 1 POUCH (11673-602-01)	1814 g	1996-12-12	0000-00-00	No	No	Current
11673-602-07	11673060207	1814 g in 1 POUCH (11673-602-07)	1814 g	1996-12-12		No	No	Current
11673-602-80	11673060280	3630 g in 1 POUCH (11673-602-80)	3630 g	2026-09-04		No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
UP & UP 602.002/602AA Epsom Salt	Target Corporation \| Nice-Pak Products, LLC	2026-09-04	HUMAN OTC DRUG LABEL	23